|
|
|
Insider
Information: |
Foley Todd |
Relationship: |
Director, 10% Owner |
City: |
Cambridge |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
9 |
|
Direct
Shares |
0 |
|
Indirect Shares
|
24,224,604 |
|
|
Direct
Value |
$0 |
|
|
Indirect Value
|
$88,983,311 |
|
|
Total
Shares |
24,224,604 |
|
|
Total
Value |
$88,983,311 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
1
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
1
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
Percentage
Gain/Loss : |
0.0%
|
-66.1%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Celladon Corp |
CLDN |
Director |
2014-02-04 |
0 |
2014-02-04 |
1,066,775 |
Premium* |
|
Aratana Therapeutics, Inc. |
PETX |
10% Owner |
2014-03-07 |
0 |
2014-03-07 |
3,351,048 |
Premium* |
|
Chiasma, Inc |
CHMA |
Director, 10% Owner |
2015-07-21 |
0 |
2015-07-21 |
5,681,544 |
Premium* |
|
Avalo Therapeutics, Inc |
AVTX |
10% Owner |
2015-10-20 |
0 |
2015-10-20 |
595,436 |
Premium* |
|
Radius Health Inc. |
RDUS |
Former 10% stockholder |
2016-09-27 |
0 |
2016-09-27 |
1,427,698 |
Premium* |
|
Rhythm Pharmaceuticals, Inc. |
RYTM |
Director |
2017-10-10 |
0 |
2021-03-15 |
909,258 |
Premium* |
|
Harpoon Therapeutics, Inc. |
HARP |
10% Owner |
2019-02-12 |
0 |
2019-02-12 |
4,524,425 |
Premium* |
|
Repare Therapeutics Inc. |
RPTX |
Director |
2020-06-23 |
0 |
2021-07-12 |
2,242,636 |
Premium* |
|
Entrada Therapeutics, Inc. |
TRDA |
Director, 10% Owner |
2021-11-02 |
0 |
2021-11-02 |
4,425,784 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
86 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
RYTM |
Rhythm Pharmaceuticals, I... |
Director |
|
2020-03-20 |
4 |
AS |
$15.00 |
$16,500 |
I/I |
(1,100) |
2,361,763 |
0 |
% |
|
RYTM |
Rhythm Pharmaceuticals, I... |
Director |
|
2020-03-26 |
4 |
AS |
$15.04 |
$34,592 |
I/I |
(2,300) |
2,359,463 |
0 |
% |
|
RYTM |
Rhythm Pharmaceuticals, I... |
Director |
|
2020-03-31 |
4 |
AS |
$15.16 |
$289,677 |
I/I |
(19,108) |
2,340,355 |
0 |
% |
|
RYTM |
Rhythm Pharmaceuticals, I... |
Director |
|
2020-04-01 |
4 |
AS |
$15.10 |
$233,476 |
I/I |
(15,462) |
2,324,893 |
0 |
% |
|
RYTM |
Rhythm Pharmaceuticals, I... |
Director |
|
2020-04-28 |
4 |
AS |
$20.07 |
$317,628 |
I/I |
(15,826) |
2,309,067 |
0 |
% |
|
RYTM |
Rhythm Pharmaceuticals, I... |
Director |
|
2020-04-29 |
4 |
AS |
$20.12 |
$410,388 |
I/I |
(20,397) |
2,288,670 |
0 |
% |
|
RYTM |
Rhythm Pharmaceuticals, I... |
Director |
|
2020-05-06 |
4 |
AS |
$20.00 |
$32,520 |
I/I |
(1,626) |
2,287,044 |
0 |
% |
|
RYTM |
Rhythm Pharmaceuticals, I... |
Director |
|
2020-05-07 |
4 |
AS |
$20.01 |
$4,002 |
I/I |
(200) |
2,286,844 |
0 |
% |
|
RYTM |
Rhythm Pharmaceuticals, I... |
Director |
|
2020-05-08 |
4 |
AS |
$20.05 |
$132,992 |
I/I |
(6,633) |
2,280,211 |
0 |
% |
|
RYTM |
Rhythm Pharmaceuticals, I... |
Director |
|
2020-05-11 |
4 |
AS |
$20.34 |
$450,633 |
I/I |
(22,155) |
2,258,056 |
0 |
% |
|
RYTM |
Rhythm Pharmaceuticals, I... |
Director |
|
2020-05-12 |
4 |
AS |
$20.23 |
$492,439 |
I/I |
(24,342) |
2,233,714 |
0 |
% |
|
RYTM |
Rhythm Pharmaceuticals, I... |
Director |
|
2020-05-13 |
4 |
AS |
$20.04 |
$36,813 |
I/I |
(1,837) |
2,231,877 |
0 |
% |
|
RYTM |
Rhythm Pharmaceuticals, I... |
Director |
|
2020-05-18 |
4 |
AS |
$20.00 |
$426,980 |
I/I |
(21,349) |
2,210,528 |
0 |
% |
|
RYTM |
Rhythm Pharmaceuticals, I... |
Director |
|
2020-05-19 |
4 |
AS |
$20.00 |
$52,660 |
I/I |
(2,633) |
2,207,895 |
0 |
% |
|
RYTM |
Rhythm Pharmaceuticals, I... |
Director |
|
2020-05-20 |
4 |
AS |
$20.01 |
$210,645 |
I/I |
(10,527) |
2,197,368 |
0 |
% |
|
RYTM |
Rhythm Pharmaceuticals, I... |
Director |
|
2020-05-21 |
4 |
AS |
$20.25 |
$518,279 |
I/I |
(25,594) |
2,171,774 |
0 |
% |
|
RYTM |
Rhythm Pharmaceuticals, I... |
Director |
|
2020-05-22 |
4 |
AS |
$20.13 |
$541,618 |
I/I |
(26,906) |
2,144,868 |
0 |
% |
|
RYTM |
Rhythm Pharmaceuticals, I... |
Director |
|
2020-05-26 |
4 |
AS |
$20.47 |
$909,298 |
I/I |
(44,421) |
2,100,447 |
0 |
% |
|
RYTM |
Rhythm Pharmaceuticals, I... |
Director |
|
2020-05-27 |
4 |
AS |
$20.13 |
$204,279 |
I/I |
(10,148) |
2,090,299 |
0 |
% |
|
RYTM |
Rhythm Pharmaceuticals, I... |
Director |
|
2020-05-28 |
4 |
AS |
$20.19 |
$386,679 |
I/I |
(19,152) |
2,071,147 |
0 |
% |
|
RYTM |
Rhythm Pharmaceuticals, I... |
Director |
|
2020-06-01 |
4 |
AS |
$20.08 |
$211,543 |
I/I |
(10,535) |
2,060,612 |
0 |
% |
|
RYTM |
Rhythm Pharmaceuticals, I... |
Director |
|
2020-06-02 |
4 |
AS |
$20.23 |
$315,143 |
I/I |
(15,578) |
2,045,034 |
0 |
% |
|
RYTM |
Rhythm Pharmaceuticals, I... |
Director |
|
2020-06-03 |
4 |
AS |
$20.27 |
$369,826 |
I/I |
(18,245) |
2,026,789 |
0 |
% |
|
RYTM |
Rhythm Pharmaceuticals, I... |
Director |
|
2020-06-05 |
4 |
AS |
$20.00 |
$37,920 |
I/I |
(1,896) |
2,024,893 |
0 |
% |
|
RPTX |
Repare Therapeutics Inc. |
Director |
|
2020-06-23 |
4 |
B |
$20.00 |
$5,000,000 |
I/I |
250,000 |
3,003,772 |
2.1 |
- |
|
86 Records found
|
|
Page 2 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|